These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147 [TBL] [Abstract][Full Text] [Related]
3. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction. Daniell HB; Privitera PJ; Conradi SE; Gaffney TE J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755 [TBL] [Abstract][Full Text] [Related]
4. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488 [TBL] [Abstract][Full Text] [Related]
5. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits. Rao Y; Wang YL; Zhang WS; Liu J Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844 [TBL] [Abstract][Full Text] [Related]
6. Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necrosis after acute coronary artery occlusion and surgical reperfusion. Melendez FJ; Gharagozloo F; Sun SC; Benfell K; Austin RE; Shemin RJ; Cohn LH J Thorac Cardiovasc Surg; 1988 Apr; 95(4):613-7. PubMed ID: 3352294 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion. Chiariello M; Ambrosio G; Cappelli-Bigazzi M; Nevola E; Perrone-Filardi P; Marone G; Condorelli M J Pharmacol Exp Ther; 1987 May; 241(2):560-8. PubMed ID: 3572813 [TBL] [Abstract][Full Text] [Related]
8. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs. Heng MK; Singh BN; Norris RM; John MB; Elliot R J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the efficacy of interventions to limit ischemic injury by direct measurement of intramural carbon dioxide tension after coronary artery occlusion in the dog. Hillis LD; Khuri SF; Braunwald E; Kloner RA; Tow D; Barsamian E; Maroko PR J Clin Invest; 1979 Jan; 63(1):99-107. PubMed ID: 105016 [TBL] [Abstract][Full Text] [Related]
10. [Limitation of the area of necrosis induced by quinacrine after coronary occlusion in the dog]. Ambrosio G; Bigazzi MC; Tritto I; Focaccio A; Brigante F; Migliaccio C; Chiariello M G Ital Cardiol; 1985 Dec; 15(12):1139-46. PubMed ID: 3835093 [TBL] [Abstract][Full Text] [Related]
11. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587 [TBL] [Abstract][Full Text] [Related]
12. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion. French CJ; Zaman AK; Sobel BE Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068 [TBL] [Abstract][Full Text] [Related]
13. CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusion. Hock CE; Lefer AM Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):285-94. PubMed ID: 3755540 [TBL] [Abstract][Full Text] [Related]
14. The open artery hypothesis: beneficial effects and long-term prognostic importance of patency of the infarct-related coronary artery. CenturiĆ³n OA Angiology; 2007; 58(1):34-44. PubMed ID: 17351156 [TBL] [Abstract][Full Text] [Related]
15. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function. Xing W; Yan W; Fu F; Jin Y; Ji L; Liu W; Wang L; Lv A; Duan Y; Zhang J; Zhang H; Gao F Apoptosis; 2009 Sep; 14(9):1050-60. PubMed ID: 19590963 [TBL] [Abstract][Full Text] [Related]
16. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats]. Liu XM; Jia Z; Zhou ZQ; Xu JG Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911 [TBL] [Abstract][Full Text] [Related]
18. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine. Niemann CU; Saeed M; Akbari H; Jacobsen W; Benet LZ; Christians U; Serkova N J Pharmacol Exp Ther; 2002 Sep; 302(3):1123-8. PubMed ID: 12183671 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of melanocortin peptides in rat myocardial ischemia. Bazzani C; Guarini S; Botticelli AR; Zaffe D; Tomasi A; Bini A; Cainazzo MM; Ferrazza G; Mioni C; Bertolini A J Pharmacol Exp Ther; 2001 Jun; 297(3):1082-7. PubMed ID: 11356932 [TBL] [Abstract][Full Text] [Related]
20. Effects of immature recruitable collaterals on myocardial blood flow and infarct size after acute coronary occlusion. Ramanathan KB; Wilson JL; Ingram LA; Mirvis DM J Lab Clin Med; 1995 Jan; 125(1):66-71. PubMed ID: 7822947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]